This inventor holds 1 USPTO granted patent and 2 published patent applications and 3 EPO patents. Top assignee: Portola Pharmaceuticals, Inc.. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: The Innovations of Robert M. Wenslow
Introduction
Robert M. Wenslow is a notable inventor based in Rahway, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of factor Xa inhibitors. His work has led to advancements that are crucial for medical applications.
Latest Patents
Wenslow holds a patent for "Crystalline forms of a factor Xa inhibitor." This patent provides crystalline forms of a maleate salt of betrixaban, along with compositions and methods of preparation or use thereof. His innovative approach has the potential to enhance the efficacy of anticoagulant therapies.
Career Highlights
Throughout his career, Wenslow has worked with prominent companies in the pharmaceutical industry. He has been associated with Portola Pharmaceuticals, Inc. and Merck Sharp & Dohme Corp. His experience in these organizations has allowed him to contribute to significant advancements in drug development.
Collaborations
Wenslow has collaborated with talented professionals in his field, including Anjali Pandey and Vincent R. Capodanno. These collaborations have fostered an environment of innovation and have led to the successful development of new pharmaceutical solutions.
Conclusion
Robert M. Wenslow's contributions to the field of pharmaceuticals through his patent and collaborations highlight his role as an influential inventor. His work continues to impact the medical community positively.